SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPetards Regulatory News (PEG)

Share Price Information for Petards (PEG)

Share Price is delayed by 15 minutes
Get Live Data
9.50    0.00 (0.00%)
Bid:
9.00
Ask:
10.00
Spread: 1.00 (11.111%)
Market Cap: £5.77m
PEG Live PriceLast checked at - London Stock Exchange

Intraday Petards Share Chart

Capital Reorganisation

7 Jun 2011 08:40

RNS Number : 9762H
Petards Group PLC
07 June 2011
Β 

ο»Ώ

7 June 2011

Β 

PETARDS GROUP PLC

(AIM: PEG)

Β 

Capital Reorganisation

Β 

Petards Group plc ("Petards" or "the Company"), the AIM quoted developer of advanced security and surveillance systems, announces that the Notice of 2011 AGM and Annual Report and Accounts for the year ended 31 December 2010 have been sent to shareholders. In addition, the Company has sent notice of a circular and notice of a general meeting convened to approve a proposed capital reorganisation. The above documents can be viewed from the Company's website, www.petards.com.

Β 

Background to and reasons for the Capital Reorganisation

Β 

The Company's share price has been below the nominal value of its Existing Ordinary Shares for some time. Company law prohibits companies from issuing new shares at less than the nominal value, therefore at present the Company is restricted as to how it can use its shares: for example, it would currently be unable to raise new share capital from investors.

Β 

At close of business on 26 May 2011, the latest practical date prior to publication of the Circular, the Company had 14,132 Shareholders of which 13,502 had shareholdings of less than 10,000 shares. These 13,502 Shareholders account for 95 per cent. of the Shareholders by number, but represent 1.6 per cent. of the total number of Existing Ordinary Shares.

Β 

At the closing bid price of 0.35 pence on 26 May 2010, the latest practical date prior to the publication of the Circular, the market value of 10,000 shares would be Β£35. The Directors consider that should a shareholder with less than 10,000 shares choose to sell their shares, the proceeds will be significantly reduced or even completely eliminated by the dealing costs of selling. Therefore the Directors recognise that for small Shareholders it is uneconomic for them to dispose of their shares. The Capital Reorganisation will allow certain small Shareholders to realise value for their shares free of dealing costs.

Β 

Another benefit of the Capital Reorganisation is it will allow the Company to reduce certain costs associated with maintaining a large shareholder register in particular printing, postage and registrars' costs.

Β 

For the reasons set out above, the Directors are proposing to reorganise the Company's share capital on the terms set out below.

Β 

Capital Reorganisation

Β 

Under the Capital Reorganisation, the Existing Ordinary Shares will be consolidated into New Consolidated Ordinary Shares on the basis of one New Consolidated Ordinary Share for each 10,000 Existing Ordinary Shares. Each New Consolidated Ordinary Share will then be sub-divided into 100 New Ordinary Shares and 9,900 Deferred Shares.

Β 

Any fractions arising as a result of the Consolidation will be aggregated and, following the Sub-division, the Directors will, in accordance with the Articles sell the aggregated shares in the market for the benefit of the relevant Shareholders.

Β 

The proceeds from the sale of the fractional entitlements shall be distributed pro rata amongst the relevant Shareholders save that where a Shareholder is entitled to an amount which is less than Β£3 it will (in accordance with the Articles) not be distributed to such Shareholder but will be retained by the Company for its benefit.

Β 

One consequence of the Capital Reorganisation is that Shareholders holding less than 10,000 Existing Ordinary Shares will receive no New Ordinary Shares.

Β 

Shareholders holding 10,000 Existing Ordinary Shares will receive 100 New Ordinary Share and 9,900 Deferred Shares.

Β 

The rights attaching to the New Ordinary Shares will be identical in all respects to those of the Existing Ordinary Shares.

Β 

The Deferred Shares will have no voting rights and will not carry any entitlement to attend general meetings of the Company. They will carry only the right to participate in any return of capital to the extent of the amount paid up or credited as paid up on each Deferred Share but only after the holder of each New Ordinary Share has received in aggregate capital repayments amounting to Β£10,000,000 per New Ordinary Share. Accordingly, the Deferred Shares will, for all practical purposes, be valueless and it is the Board's intention, at an appropriate time, to cancel the Deferred Shares.

Β 

Existing share certificates will cease to be valid following the Capital Reorganisation. New share certificates in respect of the New Ordinary Shares will be issued by 8 July 2011. No certificates will be issued in respect of the Deferred Shares, nor will CREST accounts of Shareholders be credited in respect of any entitlement to the Deferred Shares. No application will be made for the Deferred Shares to be admitted to trading on AIM or any other investment exchange.

Β 

A CREST Shareholder will have their CREST account credited with their New Ordinary Shares following their Admission, which is expected to be on 1 July 2011.

Β 

A General Meeting to obtain the necessary approval has been convened for 30 June at 11.15 p.m. Capital Reorganisation. The Capital Reorganisation is conditional upon the approval of the Shareholders at the GM as required by the Companies Act 2006 and the Articles.

Β 

The Definitions which apply in the Circular have been used in this announcement.

Β 

Contacts:

Petards Group plc

www.petards.com

Andy Wonnacott, Finance Director

+44 (0) 191 420 3000

WH Ireland Limited

www.wh-ireland.co.uk

Mike Coe / Marc Davies

+44 (0) 117 945 3470

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
CAREAXKXEDPFEEF
Date   Source Headline
20th May 202612:07 pmRNSResult of AGM
20th May 20267:00 amRNS-RContract Win
23rd Apr 20267:00 amRNSPosting of Annual Report and Notice of AGM
15th Apr 20267:01 amRNSDirector Appointment
15th Apr 20267:00 amRNSFinal results for the year ended 31 December 2025
27th Mar 20267:00 amRNSContract Wins
13th Feb 20267:00 amRNSDirector/PDMR Shareholding
9th Feb 20267:00 amRNSGrant of Share Options
5th Feb 20267:00 amRNSTrading Update
15th Dec 20257:00 amRNS-RDefence Order
2nd Dec 20259:00 amRNSNew Defence Contract Award
21st Nov 20257:00 amRNSContract extension
12th Nov 20254:41 pmRNSHolding(s) in Company
27th Oct 20259:00 amRNSRail Order Win
18th Sep 20257:00 amRNSInterim results
12th Sep 202510:51 amRNSNotice of Interim Results
12th Aug 20257:00 amRNS-RContract Win
6th Aug 202512:09 pmRNSResult of AGM
5th Aug 20257:00 amRNSMulti-year framework agreement renewal
29th Jul 20257:00 amRNS-RContract Renewal
30th Jun 20254:15 pmRNSPosting of Annual Report and Notice of AGM
24th Jun 20257:00 amRNS-RSaaS licensing renewal
23rd Jun 20257:00 amRNSFinal results for the year ended 31 December 2024
10th Jun 202512:17 pmRNSHolding(s) in Company
9th Jun 20257:00 amRNS-RContract Win
28th May 20259:26 amRNS-RPetards Rail wins Alstom CSR Award
19th Mar 20258:39 amRNS-R‘Made in the North East’ Awards 2025
20th Feb 20257:00 amRNS-RContract Win
6th Feb 20253:33 pmRNSDirector/PDMR Shareholding
4th Feb 20254:49 pmRNSHolding(s) in Company
4th Feb 20254:45 pmRNSDirector/PDMR Shareholding
4th Feb 20259:33 amRNSDirector/PDMR Shareholding
30th Jan 20257:00 amRNSTrading Update
20th Jan 20257:00 amRNSDirectorate Change
14th Jan 20257:00 amRNSHolding(s) in Company
30th Sep 20247:00 amRNSInterim Results
25th Sep 20247:00 amRNSContract Win
24th Sep 202412:28 pmRNSContract Win
3rd Sep 20247:00 amRNSContract Wins
23rd Aug 20241:35 pmRNSContract Win
25th Jul 202411:33 amRNSResult of AGM
15th Jul 20247:00 amRNSChange of Adviser
24th Jun 20244:45 pmRNSPosting of Annual Report and Notice of AGM
14th Jun 20247:00 amRNSCompletion of Acquisition
13th Jun 20247:01 amRNSAcquisition
13th Jun 20247:00 amRNSFinal Results
23rd Feb 20247:00 amRNSHolding(s) in Company
19th Feb 20247:00 amRNSContract Win
14th Feb 20247:00 amRNSContract Extension
30th Jan 20247:00 amRNSContract Win

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.